Faculty Collaboration Database -

CURRICULUM VITAE

Dennis Han MD

Emeritus Professor
Department of Ophthalmology


OFFICE ADDRESS:
925 North 87th Street

Milwaukee, WI 53226


EDUCATION:
1975 - 1978 A.B. University of Michigan
1978 - 1981 M.D. University of Michigan
Ishpeming High School, Ishpeming, MI


POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1981 - 1982 Internship, Internal Medicine, University of Vermont, Burlington, VT
08/1982 - 01/1983 Pre-residency Research Fellowship, Neuro-ophthalmology, University of Iowa Hospitals, Iowa City, IA
1983 - 1986 Residency, Ophthalmology, University of Iowa Hospitals, IA
1986 - 1987 Fellowship Vitreoretinal Diseases, Medical College of Wisconsin, Milwaukee, WI


FACULTY APPOINTMENTS:
1986 - 1987 Assistant Instructor, Ophthalmology, Medical College of Wisconsin, WI
1987 - 1988 Assistant Professor of Ophthalmology, University of Michigan, MI
1988 - 1991 Assistant Professor of Ophthalmology, Medical College of Wisconsin, WI
1991 - 1995 Associate Professor of Ophthalmology, Medical College of Wisconsin, WI
1995 - Present Professor of Ophthalmology with Tenure, Medical College of Wisconsin, WI
2000 - 09/04/2018 Jack A. and Elaine D. Klieger Professor of Ophthalmology, Medical College of Wisconsin, WI
09/04/2018 - Present Jack A. and Elaine D. Klieger Clinical Professor of Ophthalmology, Medical College of Wisconsin, WI


ADMINISTRATIVE APPOINTMENTS:
01/01/1999 - 09/04/2018 Director, Vitreoretinal Section, Medical College of Wisconsin
01/01/1999 - 09/04/2018 Director, Clinical Electrophysiology Service, Froedtert and MCW Eye Instute
01/01/1999 - 09/04/2018 Director, Clinical Imaging Service, Froedtert and MCW Eye Institute
01/01/2011 - 12/31/2012 Co-Director, Advanced Ocular Imaging Program, Medical College of Wisconsin


EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
09/01/2014 - 10/01/2015 Director, Committee to Establish the Gary W. Abrams Lectureship, Ophthalmology, Medical College of Wisconsin


RESEARCH ADMINISTRATIVE APPOINTMENTS:
04/15/1993 - 09/04/2018 Director, Thomas M. Aaberg Retina Research Fund, Ophthalmology, Vitreoretinal Section, Medical College of Wisconsin


SPECIALTY BOARDS AND CERTIFICATION:


Board Certified	Issue Date	Expiration
Diplomate, National Board of Medical Examiners	07/01/1982	None
American Board of Ophthalmology	05/14/1988	None


Licensure	Number	Issue Date	Expiration
Wisconsin Physician's License	27650	07/1986	None
Michigan Physician's License	051989	07/1987	01/1991


AWARDS AND HONORS:
1974 - Present Michigan Mathematics Prize Competition Top 100 Student of 22,000 participants
1975 - Present Valedictorian, National Merit Scholar, Ishpeming High School
1978 - Present Phi Beta Kappa of Michigan
1980 - Present Alpha Omega Alpha Honor Medical Society of Michigan
1981 - Present Graduation with Distinction, University of Michigan Medical School
1984 - Present P.J. Leinfelder Award for Best Resident Seminar
1993 - Present American Academy of Ophthalmology Honor Award Recipient
1996 - Present Award of Excellence in Education, for ProVision: Preferred Responses in Ophthalmology, Series 2, Print-Based Education Program Category, from the American Society of Association Executives
1996 - Present Listed in Woodward/White's The Best Doctors in America: Midwest Region, 1996-1997
1997 - Present Listed in Woodward/White's The Best Doctors in America: Midwest Region, 1998-1999
1998 - Present Vitreous Society Honor Award for Outstanding Service to Scientific and Educational Programs
2000 - Present Jack A. and Elaine D. Klieger Endowed Professorship in Ophthalmology, Medical College of Wisconsin
2002 - Present American of Academy Ophthalmology Senior Achievement Award Recipient
2003 - Present Listed in Best Doctors in America
2003 - Present American Society of Retina Specialists Senior Honor Award in recognition of contributions to scientific and educational programs
2004 - 2005 Listed in Guide to America's Top Ophthalmologists, Consumers' Research Council of America
2011 - 2012 Who'sWho in Medicine and Healthcare, Marquis Who'sWho Publications
2016 - Present OSN Retina Top 150 Innovators in Medical and Surgical Retina, Ocular Surgery News
2017 - Present American Academy of Ophthalmology Life Achievement Award
2017 - Present America's Best Physicians, National Consumer Advisory Board
2017 - Present "M" Milwaukee Lifestyle Magazine 2017 Best Doctor
2017 - Present Top Performer in Patient Experience, Froedtert Hospital and Medical College of Wisconsin


MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1980 - Present Alpha Omega Alpha Honor Medical Society
1983 - Present American Academy of Ophthalmology
1984 - Present Association for Research in Vision and Ophthalmology
1986 - Present Eye Institute Alumni Association
1987 - 1988 Michigan Ophthalmological Society
1987 - Present Iowa Eye Association
1987 - 1997 Fluorescein Interpretation and Review Study Tribunal (F.I.R.S.T.)
1987 - Present Wisconsin Academy of Ophthalmology 1987-
1988 - Present Aspen Retinal Detachment Society
1988 - Present Milwaukee Ophthalmological Society
1988 - Present Wisconsin-Upper Michigan Ophthalmological Society
1989 - Present American Society of Retina Specialists
1990 - Present Macula Society
1991 - Present Retina Society
1997 - Present Campo Society
2004 - Present American Ophthalmological Society


EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
10/2005 - 2010 Archives of Ophthalmology
Editorial Board
01/01/2011 - 02/15/2017 Archives of Ophthalmology/JAMA-Ophthalmology
02/15/2017 - 04/01/2019 Member, Advisory Committee, JAMA Ophthalmology
Journal Review
1987 - Present Ophthalmology
1988 - Present Archives of Ophthalmology
1989 - Present Journal of the American Medical Association
1990 - Present American Journal of Ophthalmology
1992 - Present Ophthalmologica
1992 - Present Retina
1992 Microsurgery
1997 - Present Ophthalmic Surgery and Lasers
1997 - Present Investigative Ophthalmology and Visual Science
2000 - Present Journal of Infectious Diseases
2002 - Present British Journal of Ophthalmology
2004 - Present Ophthalmic Plastic and Reconstructive Surgery
2009 - Present Eye Research
2018 - Present Survey of Ophthalmology


LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1991 - 1993 Steering Committee Director, ex officio, organizing establishment of the Thomas M Aaberg Retina Research Fund, Thomas M. Aaberg Retina Research Fund Steering Committee, Medical College of Wisconsin
09/01/2002 - 08/30/2004 Chairman, Nominating Committee, Retina Society
03/14/2012 - 04/01/2019 Board of Directors Member, Prevent Blindness Wisconsin
07/01/2012 - 07/01/2014 Member, Credentials Committee, Macula Society
2013 - 2015 Steering Committee Director, establishing the Gary W. Abrams Lectureship, Gary Abrams Lectureship Steering Committee, Medical College of Wisconsin
01/09/2017 - 09/04/2018 Member, Audit Committee, Retina Society


NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
01/22/2014 - 12/31/2016 Voting Member, Data and Safety Monitoring Committee, NEI Sponsored Study of Comparative Treatments for Retinal Vein Occlusion 2 Study (SCORE2)
04/01/2015 - Present Member, American Board of Ophthalmology Exam Development Committee, American Board of Ophthalmology
05/2015 - 11/2017 Voting Member, Data and Safety Monitoring Committee, Tyrogenex Inc.: A randomized, double-masked, placebo-controlled, non-inferiority study of X-82 plus prn Eylea compared to prn Eylea monotherapy in neovascular AMD
01/2017 - 08/2019 Voting Member, Data and Safety Monitoring Committee, Opthea: Phase II, A dose-ranging study of intravitreal OPT-302 in combination with ranibizumab, compared with ranibizumab alone, in participants with neovascular age-related macular degeneration (wet AMD)
07/2018 - 09/2020 Voting Member, Data and Safety Monitoring Committee, Apellis: Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (APL2-303/304) – Derby/Oaks Trials
10/2018 - 2022 Voting Member, Data and Safety Monitoring Committee, NIH-sponsored Diabetes Prevention Program Outcomes Study, Phase III; An evaluation of the long-term effects of DPP interventions on the development of diabetes, microvascular and selected health outcomes, the established and putative risk factors for those outcomes, and the costs and cost-utility associated with delay or prevention of diabetes.
10/2019 - 11/2022 Voting Member, Data Safety and Monitoring Committee, Aura Biosciences:A Phase 1b/2 Open-label, Ascending Single and Repeat Dose Clinical Trial Designed To Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects with Small to Medium Primary Choroidal Melanoma
10/2020 - Present Voting Member, Data and Safety Monitoring Committee, Opthea: A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination with Ranibizumab, Compared with Ranibizumab Alone, in Participants with Neovascular Age-related Macular Degeneration (nAMD); OPT 302-1004 (SHORE) and 302-1005 (COAST)
10/2020 - Present Voting Member, Data and Safety Monitoring Committee, NEI-sponsored jointly with Luxa Biotechnologies: A Phase1/2a, Open-Label Study to Evaluate the Safety and Tolerability of RPESC-derived RPE Transplantation as Therapy for Dry Age-related Macular Degeneration (AMD)
03/2021 - Present Voting Member, Data Safety and Monitoring Committee, Apellis:Phase III, Open-label, Multicenter, Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Subjects with Geographic Atrophy Secondary to Age-related Macular Degeneration (APL2-GA-305)

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:


Prior
Peer Review
Title:	Treatment of Neovascular ARMD with Advanced Visual Loss
Source:	Vitreoretinal Surgery Foundation
Role & Effort:	P.I. Corresponding Author
PI:	Dennis Han, MD
Dates:	11/30/2015 - 11/30/2017

Title:	Listing pf previous grants provided upon request


INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
International
Keynote lecturer: Applying Lean Manufacturing Processes to Ophthalmic Practice: Improving Quantity and Quality, 39th National Congress of the Brazilian Vitreoretinal Society, Sao Paolo, Brazil, 04/10/2014 - 04/11/2014
Invited lectures: Current management of endophthalmitis, adaptive optics imaging of the retina, cataract surgery and retinal disease, retinal electrophysiology, Costa Rica National Congress of Ophthalmology, Herradura, Costa Rica, 08/21/2014 - 08/23/2014

National
Han DP, Routine Intraoperative OCT Useful for Macular Surgery: CON, American Academy of Ophthalmology Subspecialty Day--Retina, Las Vegas, NV, 11/13/2015
Han DP, Lean Office, American Academy of Ophthalmology Subspecialty Day, Chicago, IL, 10/14/2016
Han DP, Ophthalmology Case Studies: Applying Lean Principles to Real Life, Association of University Professors of Ophthalmology 52nd Annual Meeting, Austin, Tx, 01/24/2018 - 01/27/2018
Han DP, Optimizing Staffing in a Lean Environment, Association of University Professors of Ophthalmology 52nd Annual Meeting, Austin, Tx, 01/24/2018 - 01/27/2018
Han DP, The Lean Toolbox: Identifying and Eliminating Waste from Clinic Processes, Association of University Professors of Ophthalmology 52nd Annual Meeting, Austin, TX, 01/24/2018 - 01/27/2018
Founders Lecture: Anti-VEGF Therapy of Neovascular AMD with Advanced Visual Loss: Going Where Few Randomized Trials Have Gone Before, Aspen Retinal Detachment Society 49th Annual Scientific Meeting, Snowmass, CO, 03/08/2021

Regional
William H. Havener Memorial Lectureship, 54th Annual Postgraduate Symposium in Ophthalmology, The Ohio State University, Toledo, OH, 03/04/2011 - 03/05/2011
Thomas M. Aaberg Lectureship: Endophthalmitis and Myths Debunked, Georgia Society of Ophthalmology, Hilton Head, SC, 05/27/2012 - Present
Han DP, Applying Lean Manufacturing Principles to Ophthalmic Practice, 9th Annual Retina Symposium, Illinois Eye and Ear Infirmary, Chicago, IL, 04/22/2016 - Present
Han DP, Anti-VEGF Therapy for ARMD and Severe Visual Loss: Going Where No Trial Has Gone Before, 9th Annual Retina Symposium, Illinois Eye and Ear Infirmary, Chicago, IL, 04/22/2016 - Present
Han DP, Applying Lean Principles to Improve Quality and Productivity in Ophthalmic Care, Nashville Academy of Ophthalmology, Nashville, TN, 09/25/2017 - Present
Han DP, Lean for Ophthalmic Practice, University of Wisconsin Department of Ophthalmology and Visual Sciences Grand Rounds, Madison, WI, 01/19/2018 - Present
Han DP, Achieving Synchrony in Clinic Flow, Grand Rounds Lecturer, Edward S. Harkness Eye Institute, Columbia University, 11/08/2018
Hogan-Ferguson Ethics Lectureship: Medical Professionalism--Meeting Our Commitment through Efficient Care, 39th Alamo City Ophthalmology Conference, University of Texas Health Center, San Antonio, TX, 04/06/2019 - Present
Han DP, Achieving Synchrony in Clinic Flow, Wisconsin Academy of Ophthalmology Annual Eye MD Symposium, Milwaukee, WI, 11/15/2019 - 11/16/2019
4th Annual Gary W. Abrams Lectureship: Endophthalmitis and Postoperative Inflammation, MCW Annual Midwinter Retina Symposium, Milwaukee, WI, 03/07/2020


MCW TEACHING ACTIVITIES:
Medical Student Education
1988 - 1998 Course Director, Medical Student Ophthalmology Senior Electives
1988 - Present Clerkship director, Senior Medical Student Elective in Retina/Vitreous Diseases
1988 - Present Senior Medical Student Advisor
1988 - 1989 Clerkship director, Third year medical student rotation in ophthalmology
1988 - 1998 Course Coordinator/Instructor, Sophomore ICM Physical Diagnosis Course in Ophthalmology
1988 - Present Clerkship director, Third Year Medical Student Required Rotation in Ophthalmology
11/05/1993 Medical Student Counselor in Ophthalmology, Specialty Day for First and Second Year Medical Students
2008 - Present Medical Student Clinical Advisor, (advising students on curriculum and career planning)
07/01/2016 - Present MCW Program Mentor (James Wu, Medical Student, Process Improvement Curriculum)

Resident and Fellow Education
08/01/1988 - 06/30/2018 Trained 38 Vitreoretinal Fellows
04/14/1992 Counselor in Ophthalmology, Third Annual Residency Day Symposium
03/2020 - Present Director and Content Creator, Retina Quiz Resident and Fellow Educational Activity


EXTRAMURAL TEACHING:
Continuing Medical Education
1989 - 1991 Senior Instructor, American Academy of Ophthalmology Instruction Course Program, "Techniques and applications of postvitrectomy fluid-gas exchange"
03/18/1990 - 03/24/1990 Course Instructor, XXVI International Congress of Ophthalmology, "Advanced vitreoretinal surgical techniques for complications of diabetic retinopathy, " Singapore
1991 - Present American Board of Ophthalmology, Associate Examiner
1992 - 1994 Associate Instructor, American Academy of Ophthalmology Instruction Course Program, "Pars Plana Microsurgical Management of Lenticular and IOL Complications"
1993 - Present Associate Instructor, American Academy of Ophthalmology Instruction Course Program, "Advances in Vitreoretinal Surgery"
1993 - Present Associate Instructor, American Academy of Ophthalmology Skills Transfer Course, "Diabetes 2000 Workshop on Diabetic Retinopathy"
1994 - 1996 Associate Instructor, American Academy of Ophthalmology Instruction Course Program, "Perioperative Care of Cataract Patients With Co-Existing Retinal Disease"
10/1999 Instructor, Pan-American Association of Ophthalmology Instruction Course Program "Update on the management of diabetic retinopathy"
2001 - 2005 Senior Instructor, American Academy of Ophthalmology Instruction Course Program, "Posterior segment complications of anterior segment surgery"
10/21/2002 Instructor/moderator, American Academy of Ophthalmology 2002 Breakfast with the Experts Roundtable Program, "Endophthalmitis Update, " Orlando, FL
10/01/2005 Associate Instructor, 4th International Conference on Ocular Infections. "Update on Endophthalmitis: Post-traumatic and Endogenous Endophthalmitis. Sapporo, Japan
2005 - 2009 Associate Instructor, American Academy of Ophthalmology Instruction Course Program, "Improving Macular Hole Surgery."
01/2006 - Present Member, Program Development Committee, ProVision: Preferred Responses in Ophthalmology, Continuing Education Print-Based program, American Academy of Ophthalmology
10/2009 Associate Instructor, Pan-American Association of Ophthalmology Instruction Course Program, "Postoperative Bacterial Endophthalmitis, " San Francisco, CA
11/11/2017 American Academy of Ophthalmic Executives, Associate instructor, The Lean Practice: Concrete Strategies for Unlocking Your Practices's Profitability and Patient Satisfaction; AAO Annual Meeting, New Orleans
11/12/2017 American Academy of Ophthalmology, Senior instructor, Lean for Retina Practices; AAO Annual Meeting, New Orleans
11/13/2017 American Academy of Ophthalmology, Panelist, Expert Opinion Leader, Spotlight on Cataract Complications; AAO Annual Meeting, New Orleans


COMMUNITY SERVICE ACTIVITIES:
07/1995 Faculty ophthalmologist, Prevent Blindness-Wisconsin, "Sight-saving Sabbath" glaucoma screenings
06/1996 Faculty ophthalmologist, Prevent Blindness-Wisconsin, "Sight-saving Sabbath" glaucoma screenings
07/05/1996 - 07/14/1996 Faculty ophthalmologist, ORBIS International missions: Mission to Qingdao, People's Republic of China
10/13/1996 Participant and fundraiser for Annual CROP-walk, Milwaukee
03/14/1997 Career day representative, Cumberland Elementary School, Whitefish Bay, WI
07/03/1997 - 07/13/1997 Faculty ophthalmologist, ORBIS International missions: Mission to Tashkent, Uzbekistan
10/06/1998 Speaker, Diabetes Care Support Group, Froedtert Memorial Lutheran Hospital
10/11/1998 Participant and fundraiser for Annual CROP-walk, Milwaukee
10/1999 Participant and fundraiser for Annual CROP-walk, Milwaukee
03/17/2001 - 03/24/2001 Faculty ophthalmologist, ORBIS International missions:Mission to San Jose, Costa Rica
07/2004 - Present Certified Merit Badge Counselor, Boy Scouts of America, 5/2006-present Assistant Scoutmaster, Troop 400, Polaris District, Milwaukee Council Boy Scouts of America
07/22/2006 - 08/05/2006 Adult advisor, Milwaukee Council BSA Contingent to Philmont Scout Ranch Expedition 7-23-D-3
07/19/2008 - 07/27/2008 Appalachian Service Project Volunteer, Knott County, KY
05/14/2015 - 05/15/2015 Speaker at the Eigth Annual Diabetes Symposium. Location: Italian Community Center, Milwaukee, WI Topic: Diabetic Retinopathy


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Sheagren JN, Menes BL, Han DP, Sanders JL, Sheagren MA: Technical aspects of the Staphylococcus aureus teichoic acid antibody assay. J Clin Microbiol 13(2):293-300, 1981.
2. Han DP, Thompson HS: Nomograms for the assessment of Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol 95:622-625, 1983.
3. Folk JC, Thompson HS, Han DP, Brown CK: Visual function abnormalities in central serous retinopathy. Arch Ophthalmol 102:1299-1302, 1984.
4. Han DP, Thompson HS, Folk JC: Differentiation between recently resolved optic neuritis and central serous retinopathy. Use of tests of visual function. Arch Ophthalmol 103:394-396, 1985.
5. Han DP, Folk JC, Thompson HS: Central serous retinopathy. The Farnsworth-Munsell 100-hue test and prolactin. Arch Ophthalmol 103:323-325, 1985.
6. Han DP, Folk JC: Internal limiting membrane wrinkling after argon and krypton laser photocoagulation of choroidal neovascularization. Retina 6:215-219, 1986.
7. Lewis H, Han DP, Williams GA: Management of fibrin pupillary block glaucoma after pars plana vitrectomy with intravitreal gas injection. Am J Ophthalmol 103:180-182, 1987.
8. Han DP, Lewis H, Williams GA: Management of complete iridocorneal apposition after vitrectomy. Am J Ophthalmol 103:108-109, 1987.
9. Lewis H, Aaberg TM, Abrams GW, Han DP, Krieger AE: Management of the lens capsule during pars plana lensectomy. Am J Ophthalmol 103:109-110, 1987.
10. Han DP, Abrams GW, Lewis H: Vitreoretinal photography using the 90 diopter lens. Am J Ophthalmol 103:238-239, 1987.
11. Han DP, Lewis H, Williams GA, Mieler WF, Abrams GW, Aaberg TM: Laser photocoagulation in the acute retinal necrosis syndrome. Arch Ophthalmol 105:1051-1054, 1987.
12. Folk JC, Ma C, Blodi CF, Han DP: Occlusion of bridging or avulsed retinal vessels by repeated photocoagulation. Ophthalmology 94:1610-1613, 1987.
13. Aaberg TM, Han DP: Evaluation of phenotypic similarities between Stargardt flavimaculatus and retinal pigment epithelial pattern dystrophies. Trans Am Ophthalmol Soc 85:101-119, 1987.
14. Han DP, Mieler WF, Abrams GW, Williams GA: Vitrectomy for traumatic retinal incarceration. Arch Ophthalmol 106:640-645, 1988.
15. Han DP, Abrams GW, Aaberg TM: Surgical excision of the attached posterior hyaloid. Arch Ophthalmol 106:998-1000, 1988.
16. Han DP, Sieving PA, Johnson MW, Martonyi CL: Foveal retinoschisis associated with senile retinoschisis in a woman. Am J Ophthalmol 106:107-109, 1988.
17. Lambrou FH, Devenyi RG, Han DP: Fluid-gas exchange after vitrectomy using long-acting gases in an outpatient setting. Arch Ophthalmol 106:1344, 1988.
18. Han DP, Abrams GW, Williams GA: Regression of disc neovascularization by photocoagulation in the acute retinal necrosis syndrome. Retina 8:244-246, 1988.
19. Sternberg P Jr, Han DP, Yeo JH, Barr CC, Lewis H, Williams GA, Mieler WF: Photocoagulation to prevent retinal detachment in acute retinal necrosis (ARN). Ophthalmology 95:1389-1393, 1988.
20. Han DP, Folk JC, Bratton AR: Visual loss after successful photocoagulation of choroidal neovascularization. Ophthalmology 95:1380-1384, 1988.
21. Jaffe G, Lewis H, Han DP, Williams GA, Abrams GW: Treatment of fibrin pupillary block with tissue plasminogen activator after pars plana vitrectomy. Am J Ophthalmol 108:170-175, 1989.
22. Han DP, Abrams GW: An illuminated blade for vitreoretinal membrane dissection. Am J Ophthalmol 108:200-201, 1989.
23. Han DP, Lewis HL, Lambrou F, Mieler WF, Hartz A: Mechanisms of intraocular pressure elevation after pars plana vitrectomy. Ophthalmology 96:1357-1362, 1989.
24. Wilkinson WS, Han DP, Rappley MD, Owings CC: Intraocular hemorrhage predicts neurologic injury in the shaken baby syndrome. Arch Ophthalmol 107:1472-1474, 1989.
25. Azen SP, Irvine AR, Davis MD, Stern W, Lonn L, Hilton G, Schwartz A, Boone D, Qullen- Thomas B, Lyons M, Lean JS, The Silicone Study Group: The validity and reliability of photographic documentation of proliferative vitreoretinopathy. Ophthalmology 96:352-357, 1989.
26. Lean JS, Stern WH, Irvine AR, Azen SP, The Silicone Study Group: Classification of proliferative vitreoretinopathy used in the silicone study. Ophthalmology 96: 765-771, 1989.
27. Barlow W, Azen S, The Silicone Oil Study Group: The effect of therapeutic treatment crossovers on the power of clinical trials. Controlled Clinical Trials 11:314-326, 1990.
28. Johnson MW, Han DP, Hoffman KE: The effect of scleral buckling on ocular rigidity. Ophthalmology 97:190-195, 1990.
29. Williams DF, Han DP, Abrams GW: Rebleeding in experimental traumatic hyphema treated with intraocular tissue plasminogen activator. Arch Ophthalmol 108:264-266, 1990.
30. Williams DF, Bennett SR, Abrams GW, Han DP, Mieler WF, Jaffe GJ, Williams GA: Low dose tissue plasminogen activator for treatment of postvitrectomy fibrin formation. Am J Ophthalmol 109:606-607, 1990.
31. Koenig SB, Han DP, Mieler WF, Abrams GW, Jaffe GJ, Burton TC: Combined phacoemulsification and pars plana vitrectomy. Arch Ophthalmol 108:362-364, 1990.
32. Han DP, Lewis MT, Kuhn EM, Abrams GW, Mieler WF, Williams GA, Aaberg TM: Relaxing retinotomies and retinectomies: Surgical results and predictors of visual outcome. Arch Ophthalmol 108:694-697, 1990.
33. Jaffe GJ, Abrams GW, Williams GA, Han DP: Tissue plasminogen activator for postvitrectomy fibrin formation. Ophthalmology 97:184-189, 1990.
34. Jaffe GJ, Schwartz DM, Han DP, Gottlieb M, Hartz A, McCarty D, Mieler WF, Abrams GW: Risk factors for postvitrectomy fibrin formation. Am J Ophthalmol 109:661-667, 1990.
35. Han DP, Mieler WF, Schwartz DM, Abrams GW: Management of traumatic hemorrhagic retinal detachment with pars plana vitrectomy. Arch Ophthalmol 108:1281-1286, 1990.
36. Williams DF, Peters MA, Abrams GW, Han DP, Mieler WF: A two-stage technique for intraoperative fluid-gas exchange following pars plana vitrectomy. Arch Ophthalmol 108:1484-1486, 1990.
37. Mieler WF, Ellis MK, Williams DF, Han DP: Retained intraocular foreign bodies and endophthalmitis. Ophthalmology 97:1532-1538, 1990.
38. Han DP, Wilkinson WS: Late ophthalmic manifestations of the shaken baby syndrome. J Pediatr Ophthalmol Strabismus 27:299-303, 1990.
39. Han DP: Book review: Atlas of Vitreoretinal Surgery, Freeman HM and Tolentino FI, eds. Am J Ophthalmol 110:718-719, 1990.
40. Nichols CJ, Boldt HC, Mieler WF, Han DP, Olsen K: Ocular injuries caused by elastic cords. Arch Ophthalmol 109:371-372, 1991.
41. Han DP, Murphy ML, Mieler WF, Abrams GW: Outpatient fluid-air exchange for severe postvitrectomy diabetic vitreous hemorrhage: Long-term results and complications. Retina 11:309-314, 1991.
42. Han DP, Lewandowski M, Mieler WF: Echographic diagnosis of anterior hyaloidal fibrovascular proliferation. Arch Ophthalmol 109:842-846, 1991.
43. Murray TG, Boldt HC, Lewis H, Abrams GW, Mieler WF, Han DP: A technique for facilitated dissection and visualization of the vitreous base, pars plana and pars plicata. Arch Ophthalmol 109:1458-1459, 1991.
44. Cokingtin CD, Han DP: Bilateral nongranulomatous uveitis and a post-streptococcal syndrome. Am J Ophthalmol 112:595-596, 1991.
45. Han DP, Mieler WF, Burton TC: Submacular fibrosis after photocoagulation for diabetic macular edema. Am J Ophthalmol 113:513-521, 1992.
46. The Silicone Study Group: Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial: Silicone Study report 1. Arch Ophthalmol 110:770-779, 1992.
47. The Silicone Study Group: Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial: Silicone Study report 2. Arch Ophthalmol 110:780-792, 1992.
48. Mieler WF, Glazer LC, Bennett SR, Han DP: Favourable outcome of traumatic endophthalmitis with associated retinal breaks or detachment. Can J Ophthalmol 27:348-352, 1992.
49. Boldt HC, Abrams GW, Murray TG, Han DP, Mieler WF: The lowest effective dose of tissue plasminogen activator for fibrinolysis of postvitrectomy fibrin. Retina 12(3 Suppl):S75-S79, 1992.
50. Koenig SB, Mieler WF, Han DP, Abrams GW: Combined phacoemulsification, pars plana vitrectomy and posterior chamber intraocular lens insertion. Arch Ophthalmol 110:1101-1104, 1992.
51. Michels M, Lewis H, Abrams GW, Han DP, Mieler WF, Neitz J: Macular phototoxicity caused by fiberoptic endoillumination during pars plana vitrectomy. Am J Ophthalmol 114:287-296, 1992.
52. Murray TG, Jaffe GJ, McKay BS, Han DP, Burke JM, Abrams GW: Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery. Refractive and Corneal Surgery 8:44-48, 1992.
53. Han DP, Lewandowski MF: Electro-oculography in autosomal dominant vitreoretinochoroidopathy. Arch Ophthalmol 110:1563-1567, 1992.
54. Glazer LC, Han DP, Gottlieb MS: Choroidal rupture and optic atrophy. Br J Ophthalmol 77:33-35, 1993.
55. Piper JG, Han DP, Abrams GW, Mieler WF: Perioperative choroidal hemorrhage at pars plana vitrectomy: a case control study. Ophthalmology 100:699-704, 1993.
56. Blumenkranz MS, Azen SP, Aaberg TM, Boone DC, Lewis H, Radtke N, Ryan SJ, the Silicone Study Group: Relaxing retinotomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy. Silicone Study report 5. Am J Ophthalmol 116:557-564, 1993.
57. Han DP: Retinal detachment caused by air-bag injury. Arch Ophthalmol 111:1317- 1318, 1993.
58. Han DP, Abrams GW: Perfluoropropane 12% versus 20%: effect on intraocular pressure and gas tamponade after pars plana vitrectomy. Retina 13:302-306, 1993.
59. McCuen BW, Azen SP, Stern W, Lai MY, Lean JS, Linton KLP, Ryan SJ, the Silicone Study Group: Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study report 3. Retina 13:279-284, 1993.
60. Barr CC, Lai MY, Lean JS, Linton KLP, Trese M, Abrams W, Ryan SJ, Azen SP, the Silicone Study Group: Postoperative intraocular pressure abnormalities in the Silicone Study. Silicone Study report 4. Ophthalmology 100:1629-1635, 1993.
61. Han DP, Murphy ML, Mieler WF: A modified en bloc excision technique during vitrectomy for diabetic traction retinal detachment: results and complications. Ophthalmology 101:803-808, 1994.
62. Han DP, Rychwalski PJ, Mieler WF, Abrams GW: Management of complex retinal detachment with combined relaxing retinotomy and intravitreal perfluoro-n-octane injection. Am J Ophthalmol 118:24-32, 1994.
63. Han DP, Nanda SK, O'Brien WJ, Guy J, Murray TG, Boldt HC: PerfluoronTM (perfluoro- n-octane): evaluation of acute anterior segment toxicity with short-term intravitreal use. Retina 14:219-224, 1994.
64. Han DP, Wang Q, Hartz AJ, Jaffe GJ, Murray TG, Boldt HC, Arrindell EL, Coe E, Abrams GW, Mieler WF: Postoperative fibrin formation and visual outcome after pars plana vitrectomy. Retina 14:225-230, 1994.
65. Hutton WL, Azen SP, Lee MBF, Blumenkranz MS, Lai MY, McCuen BW, Han DP, Flynn HW Jr, Ramsey RC, Ryan SJ, the Silicone Study Group: The effects of silicone oil removal. Silicone Study report 6. Arch Ophthalmol 112:778-785, 1994.
66. Wong VKW, Han DP, Kivlin JD: Stargardt's disease and hemoglobin SC retinopathy. Can J Ophthalmol 29:201-204, 1994.
67. Arrindell EL, Han DP: Branch retinal vein occlusion and chorioretinal anastomosis following photocoagulation of a choroidal neovascular membrane. Can J Ophthalmol 29:205-206, 1994.
68. deBustros S, the Vitrectomy for Prevention of Macular Holes Study Group. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial. Ophthalmology 101:1055-60, 1994.
69. Arrindell EL, Wu JC, Wolf MD, Nanda SK, Han DP, Wong EC, Abrams GW, Mieler WF, Hyde JS: High resolution MRI evaluation of blood-retinal barrier integrity following transscleral diode laser photocoagulation and retinal cryotherapy. Arch Ophthalmol 113:96-102, 1995.
70. Han DP, Pulido JS, Mieler WF: Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation. Am J Ophthalmol 119:563-570, 1995.
71. Nanda SK, Han DP: Experimental transconjunctival diode laser retinal photocoagulation through silicone scleral exoplants. Arch Ophthalmol 113:926-931, 1995.
72. Han DP, Blair JR, Nash RW, O'Brien WJ, Medina RR. Comparison of scleral tensile strength after transscleral delivery of cryopexy, diathermy, and diode laser photocoagulation. Arch Ophthalmol 113:1194-1199, 1995.
73. Cohen SM, Flynn HW Jr, Murray TG, Smiddy WE, the Postvitrectomy Endophthalmitis Study Group. Endophthalmitis after pars plana vitrectomy. Ophthalmology 102:705- 712, 1995.
74. Malinowski SM, Mieler WF, Koenig SB, Han DP, Pulido JS: Combined pars plana vitrectomy-lensectomy and open-loop anterior chamber lens implantation. Ophthalmology 102:211-216, 1995.
75. Kim JE, Han DP: Premacular hemorrhage as a sign of subacute bacterial endocarditis. Am J Ophthalmol 120:250-251, 1995.
76. Abrams GW, Azen SP, Barr CC, Lai MY, Hutton WL, Trese MT, Irvine A, Ryan SJ, the Silicone Study Group: The incidence of corneal abnormalities in the Silicone Study. Silicone Study Report 7. Arch Ophthalmol 113:764-769, 1995.
77. Han DP, Blair JR, Burke JM, Simons KB: Histopathologic study of autosomal dominant vitreoretinochoroidopathy in a 26-year-old woman. Arch Ophthalmol 113:1561-1566, 1995.
78. The Endophthalmitis Vitrectomy Study Group (EVS writing committee: Barza M, Davis M, Han DP, Kassoff A, Packo K, Rice T, Wilson L, Wisniewski S, Everett D): Results of the Endophthalmitis Vitrectomy Study: a randomized trial of vitrectomy and intravenous antibiotics for the treatment of post-operative bacterial endophthalmitis. Arch Ophthalmol 113:1479-1496, 1995
79. Kim JW, Freeman WR, El-Haig W, Maguire AM, Arevalo JF, Azen SP, the Vitrectomy for Macular Hole Study Group: Baseline characteristics, natural history and risk factors to progression in eyes with stage 2 macular holes: results from a prospective randomized clinical trial. Ophthalmology 102:1818-1829, 1995.
80. Kangas TA, Bennett SR, Flynn HW Jr, Murray TG, Rubsamen PE, Han DP, Mieler WF, Williams DF, Abrams GW. Reversible loss of light perception after vitreoretinal surgery. Am J Ophthalmol 120:751-756, 1995.
81. Cox MS, Azen SP, Barr CC, Linton KLP, Diddie KR, Lai MY, Freeman HM, Irvine A, the Silicone Study Group. Macular pucker after successful surgery for proliferative vitreoretinopathy. Silicone Study report 8. Ophthalmology 102:1884-1891, 1995.
82. Lean J, Azen SP, Lopez PF, Quan D, Lai MY, McCuen B, the Silicone Study Group. The prognostic utility of the Silicone Study classification system. Silicone Study report 9. Arch Ophthalmol. 114:286-292, 1996.
83. Diddie KR, Azen SP, Freeman HM, Boone DC, Aaberg TM, Lewis H, Radtke ND, Ryan SJ, the Silicone Study Group. Anterior proliferative vitreoretinopathy in the Silicone Study. Silicone Study report 10. Ophthalmology 107:1092-1099, 1996.
84. McDonald HR, Schatz H, Johnson RN, Abrams GW, Brown GC, Brucker AT, Han DP, Lewis H, Mieler WJ, Meyers S: Vitrectomy in eyes with peripheral retinal angioma associated with traction macular detachment. Ophthalmology 103:329-335, 1996.
85. Kim JW, Freeman WR, Azen SP, El-Haig W, Klein DJ, Bailey IL, the Vitrectomy for Macular Hole Study Group: A prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Am J. Ophthalmol 121:605-614, 1996.
86. Han DP, Wisniewski S, Wilson LA, Vine AK, Barza M, Doft BH, Kelsey SF, the Endophthalmitis Vitrectomy Study Group: Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study:. Am J Ophthalmol 122:1-17, 1996.
87. Palta M, Shen G, Allen C, Klein R, D'Alessio D, the Wisconsin Diabetes Registry. Longitudinal patterns of glycemic control and diabetes care from diagnosis in a population-based cohort with type I diabetes. Am J Epidemiol 144:954-61, 1996.
88. The Endophthalmitis Vitrectomy Study Group (EVS writing committee: Han DP, Doft BH, Kelsey SF, Barza M, Wisniewski S): Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 122:830-846, 1996.
89. Law SK, Kalenak JW, Connor TB Jr, Mieler WF, Pulido JS, Han DP, Mieler WF. Retinal complications following glaucoma aqueous-shunt surgery. Arch Ophthalmol 114:1473- 1480, 1996
90. Freeman WR, Kim JW, Azen SP, El-Haig W, Mishell D, Bailey I, the Vitrectomy for Macular Hole Study Group: Vitrectomy for the treatment of full-thickness Stage III or IV macular holes: results of a multicentered randomized clinical trial. Arch Ophthalmol 115:11-21, 1997
91. Tang WM, Pulido JS, Eckels DD, Han DP, Mieler WM, Pierce K. The association of LA-DR15 and Intermediate uveitis. Am J Ophthalmol 123:70-75, 1997.
92. Banker AS, Freeman WR, Kim JW, Azen SP, Bailey I, the Vitrectomy for Macular Hole Study Group. Visual threatening complications of surgery for full thickness macular holes. Ophthalmology 104:1442-52, 1997.
93. Hoggatt JS, Pulido JS, Nash RW, Simons KB, Han DP: The in vivo effects of a prototype diode laser coagulator/vaporizing endoprobe used to perform retinectomy and retinotomy in rabbits. Ophthalmic Surg Lasers 28:231-235, 1997.
94. Barza M, Pavan PR, Doft BH, Wisniewski SR, Wilson LA, Han DP, Kelsey SF. Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 115:1142-1150, 1997.
95. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA, and the Endophthalmitis Vitrectomy Study Group. The source of coagulase negative staphylococci in the endophthalmitis vitrectomy study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 115:357-361, 1997
96. Klein R, Palta M, Allen C, Shen G, Han DP, D'Alessio DJ, the Wisconsin Diabetes Registry. Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch Ophthalmol 115:351-356, 1997.
97. Allen C, Shen G, Palta M, Lotz B, Jacobson R, D'Alessio D, the Wisconsin Diabetes Registry. Long-term hyperglycemia is related to peripheral nerve changes at a diabetes duration of 4 years. Diabetes Care 20:1154-1158, 1997.
98. Palta M, LeCaire T, Daniels K, Shen G, Allen C, D'Alessio D, the Wisconsin Diabetes Registry. Risk factors for hospitalization in a cohort with type 1 diabetes. Am J Epidemiol 146:627-36, 1997.
99. Johnson MW, Doft BH, Kelsey SF, Barza M, Wilson LA, Barr CC, Wisniewski SR, and the Endophthalmitis Vitrectomy Study Group. The Endophthalmitis Vitrectomy Study: relationship between clinical presentation and microbiologic spectrum. Ophthalmology 104:261-272, 1997.
100. Barza M, Han DP, Doft BH. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Reply to letter to the editor from Durand M. Am J Ophthalmol 124:128-129, 1997.
101. Hejny C and Han DP. Vitrectomy for macular hole associated with pneumatic retinopexy. Retina 17:356-357, 1997.
102. Abrams GW, Azen SP, McCuen BW, Flynn HW, Lai MY, Ryan SJ, the Silicone Study Group. Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 15:335-344, 1997.
103. Wirostko WJ, Han DP, Mieler WF, Pulido JS, Connor TB, Kuhn E. Suprachoroidal hemorrhage: outcome of surgical management according to hemorrhage severity. Ophthalmology 105:2271-2275, 1998
104. Postel EA, Pulido JS, Byrnes GA, Heier J, Waterhouse W, Han DP, Mieler WF, Guse C, Wipplinger W. Long-term follow-up of iatrogenic phototoxicity. Arch Ophthalmol 116:753-757, 1998.
105. Mittra RA, Connor TB, Han DP, Koenig SB, Mieler WF, Pulido JS. Management of dislocated intraocular lenses using pars plana vitrectomy with placement of an open-loop, flexible anterior chamber lens. Ophthalmology 105:1011-1014, 1998.
106. Han DP, Mohsin N, Guse CE, Hartz A, Tarkanian CN, and the Southeastern Wisconsin Pneumatic Retinopexy Study Group. Comparison of pneumatic retinopexy and scleral buckling in the management of primary rhegmatogenous retinal detachment. Am J Ophthalmol 126:658-668, 1998.
107. Mittra RA, Huynh LT, Ruttum MS, Mieler WF, Connor TB, Han DP, Pulido JS, Dev S. Visual outcomes following lensectomy and vitrectomy for combined anterior and posterior persistent hyperplastic primary vitreous. Arch Ophthalmol 116:1190-94, 1998
108. Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Pulido JS, Connor TB. The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade. Tr Am Ophth Soc 96:143-154, 1998.
109. Han DP, Wisniewski SR, Kelsey SF, Doft BH, Barza M, Pavan PR. A comparison of microbiologic yields and complication rates of diagnostic vitreous needle aspiration and mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina 19:98-102, 1999.
110. Chaudhry N, Mieler WF, Han DP, Alfaro VD, III, Liggett P. Preoperative use of tissue plasminogen activator for large submacular hemorrhage. Ophthalmic Surg Lasers 30:176-180, 1999.
111. Dev S, Pulido JS, Tessler HH, Mittra RA, Han DP, Mieler WF, Connor TB. Progression of diabetic retinopathy after endophthalmitis. Ophthalmology 106:774-781, 1999.
112. Gonzalez-Fernandez F, Kurz D, Bao Y, Newman S, Conway BP, Young JE, Han DP, Khani SC. 11-cis retinol dehydrogenase mutations as a major cause of the congenital night-blindness disorder known as fundus albipunctatus. Mol Vis 1:41, 1999.
113. Han DP, Simons KB, Tarkanian CN, Moretti ST. Endophthalmitis from Mycobacterium bovis-bacille Calmette-Guerin after intravesicular bacille Calmette-Guerin injections for bladder carcinoma. Am J Ophthalmol 128:648-50, 1999.
114. Han DP, Wisniewski SR, Doft BH, Barza M, Pavan PR. "Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study." Reply to letter to the editor from Stroh, E. Retina 19:577-78, 1999.
115. Banker AS, Freeman WR, Azen SP, Lai M-Y, the Vitrectomy for Macular Hole Study Group. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes. Arch Ophthalmol 117:1499-502, 1999.
116. Tang WM, Han DP. A study of surgical approaches to retinal vascular occlusions. Arch Ophthalmol 118:138-143, 2000.
117. Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Pulido JS, Connor TB. The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade. Ophthalmology 107:588-92, 2000.
118. Wirostko WJ, Mieler WF, Levin DS, Law SK, Kalenak JW, Trible JR, Connor TB Jr, Pulido JS, Han DP. Hypotony and retinal complications after aqueous humor shunt implantation: the 1999 Dohlman Lecture. Int Ophthalmol Clin 40: 1-12, 2000.
119. Amin HI, McDonald HR, Han DP, Jaffe GJ, Johnson MW, Lewis H, Lopez PF, Mieler WF, Neuwirth J, Sternberg P, Jr, Werner JC, Ai E, Johnson R. Vitrectomy update for macular traction in ocular toxocariasis. Retina 20: 80-85, 2000.
120. Mansour AM, Khoury A, Han DP, Friedman S, Salem Z, Saghir N. Ocular findings in aplastic anemia. Ophthalmologica 214: 399-402, 2000.
121. Jones BE, Jampol LM, Yannuzzi LA, Tittl M, Johnson MW, Han DP, Davis JL, Williams DF, Kauffmann DHJ. Relentless placoid chorioretinitis: a new entity or an unusual variant of serpiginous chorioretinitis? Arch Ophthalmol 118: 931-8, 2000.
122. Shastry BS, Hejtmancik JF, Hiraoka M, Ibaraki N, Okubo Y, Okubo A, Han DP, Trese MT. Linkage and candidate gene analysis of autosomal-dominant familial exudative vitreoretinopathy. Clin Genet 58:329-32, 2000.
123. Wirostko WJ, Han DP, Perkins SL. Complications of pneumatic retinopexy. Current Opinion in Ophthalmology 11:195-200, 2000.
124. Hong PH, Han DP, Burke JM, Wirostko WJ. Vitrectomy for large vitreous opacity in retinitis pigmentosa. Am J Ophthalmol 131:133-4, 2001.
125. Kim JE, Perkins SL, Schwiesow T, Connor TB, Han DP. Transpupillary thermotherapy of occult choroidal neovascularization in age-related macular degeneration. Seminars in Ophthalmology 16:86-89, 2001.
126. Doft, BH, Wisniewski SR, Kelsey SF, Fitzgerald SG, and the Endophthalmitis Vitrectomy Study Group. Diabetes and postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 119: 650-6, 2001.
127. Levin DS, Han DP, Dev S, Wirostko WJ, Mieler WF, Connor TC, Jr. Subtenon corticosteroid injections in patients with a history of corticosteroid -induced intraocular pressure elevation. Am J Ophthalmol 133:196-202, 2002.
128. Cheng L, Azen SP, El-Bradey MH, Toyoguchi M, Chaidhawangul S, Rivero ME, Scholz BM, Freeman WR, the Vitrectomy for Macular Hole Study Group. Effects of preoperative and postoperative epiretinal membranes on macular hole closure and visual restoration. Ophthalmology 109:1514-1520, 2002.
129. Mansour AM, Bashshur Z, Han DP, Kim JE. Fluorescein Angiographic findings in an infected scleral buckle. Ophthalmic Surg Lasers 33:433-435, 2002.
130. Wirostko WJ, Han DP. Endophthalmitis: treatment approach for 2002. Ophthalmic Practice 20:112-116, 2002.
131. Han DP, Bennett SR, Williams DF, Dev S. Arteriovenous crossing dissection without separation of the retinal vessels for treatment of branch retinal vein occlusion. Retina 23:145-151, 2003.
132. Han DP. Diagnostic and Therapeutic Challenges: Non-progressive pigmentary fundus changes in a 12 year old girl. (Ed., H. Richard McDonald.) Retina 23: 387-391, 2003.
133. Scott IU, Flynn HW, Murray TG, Feuer WJ, and the Perfluoron Study Group. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol 136:454-463, 2003.
134. Wirostko WJ, Han DP. Endophthalmitis: treatment approaches for 2003. Clinical and Surgical Ophthalmology 1/21: 456-462, 2003.
135. Dev S, Han DP, Mieler WF, Gonzalez-Vivas R, Pulido JS, Mittra RA, Connor TB, Jr. The role of intravitreal dexamethasone as an adjunct in the management of postoperative bacterial endophthalmitis. Journal of the European Vitreoretinal Society 1:13-20, 2004.
136. Iyer MN, Han DP, Yun HJ, Eastwood D, Kim JE, Connor TB, Wirostko WJ, Dev S. Subconjunctival antibiotics for acute post-cataract extraction endophthalmitis - Is it necessary? Am J Ophthalmol 137:1120-1121, 2004.
137. Perkins SL, Han DP, Burke JM, Schlievert P, Wirostko WJ, Tarasewicz DG, Skumatz CMB. Intravitreally Injected Human Immunoglobulin Attenuates the Effects of Staphylococcus aureus Exotoxins in a Rabbit Endophthalmitis Model. Arch Ophthalmol 122:1499-506, 2004.
138. Han DP. Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis. Trans Am Ophthalmol Soc 102:305-320, 2004.
139. Flynn HW Jr. Scott IU. Brod RD. Han DP. Current management of endophthalmitis. International Ophthalmology Clinics. 44(4):115-37, 2004.
140. Shah KB. Han DP. Proliferative diabetic retinopathy. International Ophthalmology Clinics. 44(4):69-84, 2004.
141. Moon SJ, Han DP. Acute bilateral serous macular detachment associated with gallium nitrate in a non-Hodgkin's lymphoma patient. Retina 25:212-214, 2005.
142. Moon SJ, Kim JE, Han DP. Lightning-induced maculopathy. Retina. 25:380-2, 2005.
143. Perkins SL, Han DP, Gonder JR, Cole G, Beaumont PE. Dynamic atypical optic nerve coloboma associated with transient macular detachment. Arch Ophthalmol 123:1750-4, 2005.
144. Perkins SL, Han DP, Gonder JR, Cole G, Beaumont PE. Dynamic atypical optic nerve coloboma associated with transient macular detachment. Trans Am Ophthalmol Soc 103:116-125, 2005.
145. Iyer MN, Han DP. An eye model for practicing vitreoretinal membrane peeling. Arch Ophthalmol 124:108-10, 2006.
146. Kim JE, Shah KB, Han DP, Connor TB Jr: Transpupillary Thermotherapy with Indocyanine Green Dye Enhancement for the Treatment of Occult Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration. Ophthalmic Surg Lasers Imaging 37:272-277, 2006.
147. Ryan EH Jr. Han DP. Ramsay RC. Cantrill HL. Bennett SR. Dev S. Williams DF. Diabetic macular edema associated with glitazone use. Retina. 26:562-70, 2006.
148. Prakash M, Han DP. Acute recurrent exudative macular detachments associated with photodynamic therapy in a patient with idiopathic polypoidal choroidal vasculopathy. American Journal of Ophthalmology. 142:1079-81, 2006.
149. Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, Whitcup SM, the Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 125:309-317, 2007.
150. Writing Committee for the Diabetic Retinopathy Clinical Research Network. Fong DS. Strauber SF. Aiello LP. Beck RW. Callanan DG. Danis RP. Davis MD. Feman SS. Ferris F. Friedman SM. Garcia CA. Glassman AR. Han DP. Le D. Kollman C. Lauer AK. Recchia FM. Solomon SD. Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema. Archives of Ophthalmology. 125:469-80, 2007.
151. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina 27:662-80, 2007.
152. Lemley CA, Han DP. An age-based method for planning sclerotomy placement during pediatric vitrectomy: a twelve year experience. Retina 27:974-977, 2007.
153. Mansour AM. Han DP. Kim JE. Uwaydat SH. Sibai A. Medawar WA. Li HK. Rjeily JA. Salti HI. Bashshur Z. Hourani M. Radiologic findings in infected and noninfected scleral buckles. European Journal of Ophthalmology. 17:804-11, 2007.
154. Lemley CA, Han DP. An age-based method for planning sclerotomy placement during pediatric vitrectomy: a twelve year experience. Transactions of the American Ophthalmological Society 105:86-89, 2007
155. Kim JE, Pollack JS, Miller DG, Mittra RA, Spaide RF, the ISIS Study Group. ISIS-DME. A prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema. Retina 28:735-740, 2008.
156. Han DP. Postoperative giant retinal pseudo-tear. Retina Cases and Brief Reports 2:128-129, 2008.
157. Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Jr., Kim JE. Risk factors for scleral buckle removal: a matched, case-control study. Am J Ophthalmol American Journal of Ophthalmology. 146(3):434-439, 2008.
158. Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Jr., Kim JE. Risk factors for scleral buckle removal: a matched, case-control study. Trans Am Ophthalmol Soc, 106:171-177, 2008.
159. Wirostko WJ, Covert DJ, Han DP, Connor TB, Jr., Kim JE, Hammersley J, Lindgren K. Microbiological Spectrum of Organisms Isolated from Explanted Scleral Buckles. Ophthalm Surg Lasers Imaging 40:201-2, 2009.
160. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Jumper JM, Figueroa M; SCORE Study Investigator Group. SCORE Study Report 1: Baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion. Ophthalmology. 116(3):504-12, 2009. Epub 2009 Jan 22.
161. Han DP. Perspectives on the Endophthalmitis Vitrectomy Study: Implementing its findings today. Current Insight (peer reviewed article). Ophthalmic News and Education Network, American Academy of Ophthalmology. E-published Q 1, 2009; March 18, 2009. (http://one.aao.org/CE/News/CurrentInsight/Archive.aspx)
162. Han DP, Sievers S. Extensive drusen in Type I membranoproliferative glomerulonephritis   Arch Ophthalmol 127:577-579, 2009.
163. Mittra RA, Kim JE, Han DP, Pollack JS. Sustained postoperative face-down positioning is unnecessary for successful macular hole surgery. Br J Ophthalmol. 93:664-666, 2009
164. Covert DJ, Han DP, Kim JE, Connor TB, Jr., Wirostko WJ, Moon SJ, Hamilton R. The Relationship Between Computer Calculated Estimates and Physician Assessment of Changing Lesion Size of Predominantly Classic Choroidal Neovascular Membranes in Age-Related Macular Degeneration: Sensitivity, Clinical Significance and Accuracy. Ophthalmic Surgery, Lasers, and Imaging 40:554-560, 2009
165. Kim JE, Shah SN, Choi DL, Han DP, Connor TB. Transconjunctival 20-gauge pars plana vitrectomy using a single entry cannulated sutureless system. Retina. 2009 Oct;29(9):1294-8.
166. Stepien KE, Han DP, Schell J, Godara P, Rha J, Carroll J, Spectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss. Trans Am Ophthalmol Soc. 107:28-33, 2009
167. Han DP, McAllister JT, Weinberg DV, Kim JE, Wirostko WJ. Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to macular photocoagulation. Eye 24:713-6, 2010
168. Han DP, O'Brien WJ, Higgins B. Biocompatibility of pooled human immunoglobulin (Gamunex 10%™) with ocular infusion solutions (BSS™ and BSS Plus™): an in vitro evaluation of a potential antitoxin treatment for infectious endophthalmitis. J Ocul Pharmacol Ther. 2011 Aug;27(4):343-6. PMCID: PMC3146742
169. Adam MK, Covert DJ, Stepien KE, Han DP. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity. Br J Ophthalmol. 2012 May;96(5):723-9.
170. Covert DJ, Henry CR, Bhatia SK, Croskrey J, Sanchez CR, Han DP. Intraoperative retinal tear formation and postoperative rhegmatogenous retinal detachment in transconjunctival cannulated vitrectomy systems compared with the standard 20-gauge system. Arch Ophthalmol. 2012 Feb;130(2):186-9.
171. Han DP, Croskrey JA, Dubis AM, Schroeder B, Rha J, Carroll J. Adaptive optics and SD-OCT imaging of human photoreceptor structure after short duration (20 ms) PascalTM macular grid and panretinal laser photocoagulation. Arch Ophthalmol, 2012 Apr;130(4):518-21
172. Abramoff MD, Folk JC, Han DP, Walker JD, Williams DF, Russell SR, Roller AB, Massin P, Cochener B, Gain P, Tang L, Lamard M, Moga D, Quellec G, Niemeijer M. Automated analysis of retinal images for detection of referable diabetic retinopathy. JAMA Ophthalmol. 2013 Mar;131(3):351-7. doi: 10.1001/jamaophthalmol.2013.1743.
173. Zhang HF, Wei Q, Liu T, Wang J, Han DP, Burke JM, Jiao S. Multimodal retinal imaging. OSA, in press.
174. Han DP, Croskrey JA, Dubis AM, Schroeder B, Rha J, Carroll J. Adaptive optics and spectral- domain optical coherence tomography of human photoreceptor structure after short-duration [corrected] pascal macular grid and panretinal laser photocoagulation. Arch Ophthalmol. 2012 Apr;130(4):518-21. PMCID: PMC3325792
175. Han DP, Szabo A Flashes, Floaters, and Oral Fluoroquinolones. Arch Ophthalmol. 2012 Sep 1:1-3
176. Godara P, Cooper RF, Sergouniotis PI, Diederichs MA, Streb MR, Genead MA, McAnany JJ, Webster AR, Moore AT, Dubis AM, Neitz M, Dubra A, Stone EM, Fishman GA, Han DP, Michaelides M, Carroll J. Assessing retinal structure in complete congenital stationary night blindness and Oguchi disease. Am J Ophthalmol. 2012 Dec;154(6):987-1001.e1. PMCID: PMC3498541
177. Han DP, Chin M, Simons KB, Albert DM. Surgical removal of an atypical macular epiretinal membrane in neurofibromatosis type 2: clinicopathologic correlation and visual outcome. Arch Ophthalmol. 2012 Oct;130(10):1337-9.
178. Abràmoff MD, Folk JC, Han DP, Walker JD, Williams DF, Russell SR, Massin P, Cochener B, Gain P, Tang L, Lamard M, Moga DC, Quellec G, Niemeijer M. Automated analysis of retinal images for detection of referable diabetic retinopathy. JAMA Ophthalmol. 2013 Mar;131(3):351-7.
179. Han DP, Szabo A. Flashes, floaters, and oral fluoroquinolones: is retinal detachment a worry? JAMA Ophthalmol. 2013 Jan;131(1):91-3. PMCID: PMC4183446
180. Han DP, Covert DJ, Wirostko WJ, Hammersley JA, Lindgren KE. Scleral buckle removal in the vitrectomy era: a 20-year clinical experience. Retina. 2013 Feb;33(2):387-91.
181. Reis LM, Tyler RC, Muheisen S, Raggio V, Salviati L, Han DP, Costakos D, Yonath H, Hall S, Power P, Semina EV. Whole exome sequencing in dominant cataract identifies a new causative factor, CRYBA2, and a variety of novel alleles in known genes. Hum Genet. 2013 Jul;132(7):761-70. PMCID: PMC3683360
182. Singh RS, Covert DJ, Henry CR, Bhatia SK, Croskrey J, Sanchez CR, Han DP. Retinal complications associated with pars plana vitrectomy for macular holes or epiretinal membranes in eyes with previous retinal detachment repair. JAMA Ophthalmol. 2014 Jan;132(1):118-9.
183. Han DP. The ForeSeeHome device and the HOME study: a milestone in the self-detection of neovascular age-related macular degeneration. JAMA Ophthalmol. 2014 Oct;132(10):1167-8.
184. Graves GS, Adam MK, Stepien KE, Han DP. Validation of the colour difference plot scoring system analysis of the 103 hexagon multifocal electroretinogram in the evaluation of hydroxychloroquine retinal toxicity. Acta Ophthalmol. 2014 Aug;92(5):e377-81. PMCID: PMC4199328
185. Han DP. How a manufacturing process transformed healthcare delivery. Med Econ. 2013 Jul 25;90(14):31-4.
186. Croskrey JA, Han DP. Adverse reactions to plain gut, polyglycolic Acid, and polyglactin 910 sutures for sclerotomy closure at pars plana vitrectomy. Retin Cases Brief Rep. 2013;7(3):297-9.
187. Reichstein D, Warren C, Han DP, Wirostko WW. Subtenon anesthesia is equivalent to retrobulbar anesthesia for completion of vitreoretinal procedures. Submitted for publication, 2015.
188. Swinney CC, Han DP, Karth PA. Incontinentia Pigmenti: A Comprehensive Review and Update. Ophthalmic Surg Lasers Imaging Retina. 2015 Jun;46(6):650-7.
189. Abozaid MA, Scoles D, Goldberg M, Carroll J, Han DP. En Face Optical Coherence Tomography of Outer Retinal Discontinuity and Fan-Shaped Serous Macular Detachment in Diabetic Macular Edema. JAMA Ophthalmol. 2015 Aug;133(8):961-3.
190. Scoles D, Flatter JA, Cooper RF, Langlo CS, Robison S, Neitz M, Weinberg DV, Pennesi ME, Han DP, Dubra A, Carroll J. ASSESSING PHOTORECEPTOR STRUCTURE ASSOCIATED WITH ELLIPSOID ZONE DISRUPTIONS VISUALIZED WITH OPTICAL COHERENCE TOMOGRAPHY. Retina. 2016 Jan;36(1):91-103. PMCID: PMC4843118
191. Edward L Randerson, Drew Davis, Brian Higgins, Judy E Kim, Dennis P Han, Thomas B Connor, William J Wirostko, Joseph Carroll Assessing Photoreceptor Structure in Macular Hole using Split-detector Adaptive Optics Scanning Light Ophthalmoscopy European Ophthalmic Review. European Ophthalmic Review, 2015;9(1):59–63 DOI: 10.17925/EOR.2015.09.01.59
192. Harry W Flynn Jr MD1, Charles C Wykoff MD PhD2, Nidhi Relhan MD1, Dennis P Han MD Cross-reactivity of cephalosporins among penicillin sensitive individuals. Clinical Ophthalmology.
193. Reichstein DA, Warren CC, Han DP, Wirostko WJ.Local Anesthesia With Blunt Sub-Tenon's Cannula Versus Sharp Retrobulbar Needle for Vitreoretinal Surgery: A Retrospective, Comparative Study. Ophthalmic Surg Lasers Imaging Retina. 2016 Jan 1;47(1):55-9. doi: 10.3928/23258160-20151214-08.
194. Razeen MM, Cooper RF, Langlo CS, Goldberg MR, Wilk MA, Han DP, Connor TB Jr, Fishman GA, Collison FT, Sulai YN, Dubra A, Carroll J, Stepien KE. Correlating Photoreceptor Mosaic Structure to Clinical Findings in Stargardt Disease. Transl Vis Sci Technol. 2016 Mar;5(2):6. PMCID: PMC4790429
195. Sun LW, Johnson RD, Langlo CS, Cooper RF, Razeen MM, Russillo MC, Dubra A, Connor TB Jr, Han DP, Pennesi ME, Kay CN, Weinberg DV, Stepien KE, Carroll J. Assessing Photoreceptor Structure in Retinitis Pigmentosa and Usher Syndrome. Invest Ophthalmol Vis Sci. 2016 May 01;57(6):2428-42. PMCID: PMC5089122
196. Han DP, McKenney KC, Kim JE, Weinberg DV, Musch DC, Singh RS. CLINICAL EVALUATION OF THE RAPID ACCESS VITREAL INJECTION GUIDE: A Handheld Instrument for Assisting Intravitreal Injections. Retina. 2017 Apr;37(4):778-781.
197. Vogel RN, Davis DB, Kimura BH, Rathinavelu S, Graves GS, Szabo A, Han DP. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH ADVANCED VISUAL LOSS TREATED WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: Clinical Outcome and Prognostic Indicators. Retina. 2017 Feb;37(2):257-264.
198. Hua DA, Casella AM, Berrocal MH, Han D, Alshareef RA, Quiroz-Mercado H, Arevalo JF, Chhablani J. Outcomes of anti-VEGF therapy in choroidal neovascularization after macular surgery. Retin Cases Brief Rep. 2018; 12(4):359-366.
199. Braza ME, Young J, Hammeke TA, Robison SE, Han DP, Warren CC, Carroll J, Stepien KE. Assessing photoreceptor structure in patients with traumatic head injury. BMJ Open Ophthalmol. 2018;3(1):e000104. PMCID: PMC6257382
200. Jampol LM, Odia I, Glassman AR, Baker CW, Bhorade AM, Han DP, Jaffe GJ, Melia M, Bressler NM, Tanna AP, Diabetic Retinopathy Clinical Research Network. PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial. Retina. 2019 Jan;39(1):69-78. PMCID: PMC6317708
201. Han DP, Skumatz C, Besharse JC, Kassem IS. Sustained Anti-Vascular Endothelial Growth Factor Activity of Aflibercept (Eylea) After Storage in Polycarbonate Syringes Used for Intravitreal Injection: A Pathway to Safety and Efficiency. J Ocul Pharmacol Ther. 2019 Jun;35(5):278-282. PMCID: PMC6588124
202. Cooke MD, Winter PA, McKenney KC, Packard KL, Williams V, Dorsey EA, Szabo A, Visotcky A, Warren CC, Wirostko WJ, Weinberg DV, Kim JE, Han DP. An innovative visual acuity chart for urgent and primary care settings: validation of the Runge near vision card. Eye (Lond). 2019 Jul;33(7):1104-1110. PMCID: PMC6707193
203. Wu JF, Visotcky A, Szabo A, Eyler S, Siegmann P, Griepentrog GJ, Warren CC, Han DP. Implementation of a Novel Near Visual Acuity Chart in an Emergency Department Setting. J Healthcare Quality. 2020 Sept/Oct; 42(5):e58-e65.
204. Folk JC, Clarinda W, Niemeijer M, Daniel E, Han DP, Walker J, Williams D, Graf J, Privett B, Johnson TA, Major J, Kellaway J, Pistilli M, Maguire MG, Abramoff MD. Accuracy of detection of referable diabetic retinopathy by clinical examination, vitreoretinal specialist graders and a reading center against a validated outcome standard. Under review.

Books, Chapters, and Reviews
1. Stern WH, Lean JS, and the Silicone Study Group. Intraocular silicone oil versus gas in the management of proliferative vitreoretinopathy (PVR): a multicenter clinical study. In: Proliferative Vitreoretinopathy, Freeman HM, Tolentino FI, eds. Springer-Verlag New York, Inc., New York, 1989.
2. Boldt HC, Abrams GW, Murray TG, Han DP, Mieler WF. The lowest effective dose of tissue plasminogen acivator for fibrinolysis of postvitrectomy fibrin. In Stirpe M, ed., Advances in Vitreoretinal Surgery: Acta of the Third International Congress on Vitreoretinal Surgery. Ophthalmic Communications Society, Inc., New York, NY, 1992, pp. 353-357.
3. Han DP. Diabetic Retinopathy. Chapter in: Diagnostic Problems in Clinical Ophthalmology, Margo CE, Mames RN, Hamed L, eds. WB Saunders Co., Philadelphia, 1994, pp. 513-524.
4. Abrams GW, Arrindell EL, Wolf MD, Mieler WF, Han DP. Advances in vitreous surgery: perfluorocarbon liquids. In Franklin RM, ed., Retina and Vitreous. Kugler Publications, Amsterdam/New York, 1992, pp. 237-247.
5. Han DP. Endophthalmitis. Chapter in: Practical Atlas of Retinal Disease and Therapy, 2nd edition. WR Freeman, ed. Lippincott-Raven Publishers, Philadelphia, 1998, pp. 373-382.
6. Han DP. Endophthalmitis. Chapter in: Ophthalmic Surgery: Principles and Techniques, Albert D, ed. Blackwell Scientific, In press (1997).
7. Mittra R and Han DP. Traction and exudative retinal detachment. Chapter in: Essentials of Vitreoretinal Disease, Brown GC, Flynn HW, Regillo CD, eds. Thieme Publishers, 1999, pp 491-504.
8. Dev S and Han DP. Management of traumatic lens subluxation and dislocation. Chapter in: Atlas of Vitreoretinal Surgery, Peyman GA, Meffert S, Chou F, Conway M, eds. Martin Dunitz, Ltd., 2001, pp. 435-442.
9. Han DP and Dev S. Penetrating injuries. Chapter in: Atlas of Vitreoretinal Surgery, Peyman GA, Meffert S, Chou F, Conway M, eds. Martin Dunitz, Ltd., 2001, pp. 457-473.
10. Flynn H, Brod R, Miller D, Han DP. Endophthalmitis management. Chapter in: Duane's Clinical Ophthalmology, Lippincott-Raven Publishers, (2003).
11. Flynn H, Brod R, Miller D, Han DP. Endophthalmitis management. Chapter in: Ophthalmic Surgery: Principles and Practice, G. Spaeth and W. Tasman, eds., Philadelphia, PA; Saunders; 2003:663-677.
12. Han D. Endophthalmitis. Chapter in: Clinical Atlas of Procedures in Ophthalmic Surgery. Albert DM, Lucarelli MJ, eds., AMA Press; 2004: 156-160.
13. Han D. Retina and Vitreous Surgery. Section contributor. Clinical Atlas of Procedures in Ophthalmic Surgery. Albert DM, Lucarelli MJ, eds., AMA Press; 2004: 121-185.
14. Han D. Venous Occlusive Disease. American Academy of Ophthalmology "Session Highlight" presentation, AAO 2003 Annual Meeting "Highlights CD-ROM" (2004)
15. Shah K, Han DP. Proliferative diabetic retinopathy. Chapter in: International Ophthalmology Clinics: Controversies and Advancements in the Treatment of Retinal Disease. Heier JS, ed. Lippincott Williams & Wilkins, Philadelphia; 2004; 44:69-84.
16. Flynn HW, Scott IU, Brod RD, Han DP. Current management of endophthalmitis. Chapter in: International Ophthalmology Clinics: Controversies and Advancements in the Treatment of Retinal Disease. Heier JS, ed. Lippincott Williams & Wilkins, Philadelphia; 2004; 44:115-137.
17. Han DP, editor. Supplement to Retinal Physician. October 2004 issue. Advanced Vitreoretinal Techniques and Technology. Highlights of selected papers from the summer conference held in Park City, Utah, July 16-18, 2004.
18. Kim JE, Han DP. Managing retained lens fragments. Cataract & Refractive Surgery Today 5:63-66, 2005.
19. Scott, IU, Flynn, HW, Han, DP: Endophthalmitis: categories, management and prevention. In: Tasman WE, Jaeger EA, eds. Duane's Solution, Philadelphia: Lippincott Williams & Wilkins, 2006; Vol 6, Ch 64.
20. Han DP, Dev S. Penetrating and perforating injuries. Chapter in: Vitreoretinal Surgical Techniques. Peyman GA, Meffert SA, Conway MD, eds. Informa UK Ltd, London; 2007, pp. 505-520.
21. Dev S, Han DP. Management of traumatic lens subluxation and dislocation. Chapter in: Vitreoretinal Surgical Techniques. Peyman GA, Meffert SA, Conway MD, eds. Informa UK Ltd, London; 2007, pp. 484-491.
22. Han DP. Proliferative Vitreoretinopathy. Chapter in: Principles and Practice of Ophthalmology, 3rd edition. Albert DM, ed. Elsevier, Inc., Philadelphia, 2008, Vol 2, Ch 183, pp. 2315-2324.
23. Covert DJ, Han DP. Retinal vein occlusion: epidemiology, clinical manifestations, and diagnosis. Chapter in: UpToDate: A Unique Resource for Clinicians and Patients. Trobe J and Eamranond P, eds. UpToDate, Inc. Wolters Kluwer Health, Waltham, MA, issued Oct 2010.
24. Covert DJ, Han DP. Retinal vein occlusion: treatment. Chapter in: UpToDate: A Unique Resource for Clinicians and Patients. Trobe J and Eamranond P, eds. UpToDate, Inc. Wolters Kluwer Health, Waltham, MA, issued Oct 2010. [Updated semiannually to current date (2015)]
25. Han DP. Endophthalmitis. Chapter in: Clinical Atlas of Procedures in Ophthalmic and Oculofacial Surgery. Eds. Albert DM, Lucarelli MJ, Atzen SL, Oxford University Press, Inc., Oxford, 2012, pp. 472-477.
26. Brod RD, Flynn HW, Jr, Han DP, Miller D. Endophthalmitis: diagnosis, clinical findings, and management. Chapter in: Ophthalmic Surgery: Principles and Practice, 4th Edition. Eds. Spaeth GL, Danesh-Meyer HV, Goldberg I, Kampik A, Elsevier, Edinburgh, 2012, pp. 550-560.
27. Han DP. Cataract Surgery and Retinal Disease: Optimizing Visual Outcome. Bryn Mawr Communications, Wayne, PA. 2013
28. Han DP. Postoperative inflammatory syndromes and TASS. In: Cataract Surgery and Retinal Disease: Optimizing Visual Outcome. Bryn Mawr Communications, Wayne, PA. 2013, pp. 123-130.
29. Kokame GT, and Han DP. Combining cataract surgery and posterior vitrectomy. In: Cataract Surgery and Retinal Disease: Optimizing Visual Outcome. Bryn Mawr Communications, Wayne, PA., 2013, pp. 55-60.
30. Singh RSJ and Han DP. Potential acuity testing. In: Cataract Surgery and Retinal Disease: Optimizing Visual Outcome. Bryn Mawr Communications, Wayne, PA., 2013, pp. 167-173.
31. Cooke MD, Mittra RA, Han DP. Exudative and tractional retinal detachments. In: Vitreoretinal Disease: The Essentials, 2nd Edition, Scott IU, Regillo CD, Flynn HW, and Brown GC, eds. Thieme Publishers, New York, In press.
32. Han DP, Suneja A. Make Your Clinics Flow with Synchrony. A Practical and Innovative Guide for Physicians, Managers, and Staff. ASQ Quality Press, Milwaukee, ISBN 978-0-87389-923-9, 2016

Editorials, Letters To Editor, Other
1. Wykoff CC, Flynn HW Jr, Han DP. Allergy to povidone-iodine and cephalosporins: the clinical dilemma in ophthalmic use. Am J Ophthalmol. 2011 Jan;151(1):4-6.
2. Han DP, Heuer DK. (Editorial): Intravitreal corticosteroid therapy: putting the problem of glaucoma in perspective. Arch. Ophthalmol. 130(3):380-382, 2012
3. Han DP. Age-Related Macular Degeneration, Anti-VEGF Therapy, and Ophthalmic Imaging: Is There a Best Practice? JAMA Ophthalmol 2013 Jun 6:1-3
4. Han DP. The ForeSeeHome device and the HOME study: a milestone in the self-detection of neovascular age-related macular degeneration. JAMA Ophthalmol. 2014 Oct;132(10):1167-8. doi: 10.1001/jamaophthalmol.2014.1405

Abstracts
1. Han DP, Folk JC, Thompson HS, Brown CK: Visual abnormalities in central serous retinopathy. Invest Ophthalmol Vis Sci 25(3,Suppl):253, 1984.
2. Han DP, Folk JC: Internal limiting membrane wrinkling after argon and krypton laser treatment for subretinal neovascularization. Invest Ophthalmol Vis Sci 26(3, Suppl):38, 1985.
3. Folk JC, Han DP: Photocoagulation occlusion of bridging retinal vessels. Ophthalmology 93:124,1986.
4. Han DP, Folk JC: Visual loss after photocoagulation of choroidal neovascularization. Invest Ophthalmol Vis Sci 27(3, Suppl):314, 1986.
5. Folk JC, Han DP, Cutkomp JL, Koontz FP: Intraocular inflammation secondary to infected scleral buckles. Invest Ophthalmol Vis Sci 27(3, Suppl):315, 1986.
6. Han DP, Lewis H, Williams GA, Mieler WF, Abrams GW, Aaberg TM: Laser photocoagulation in the acute retinal necrosis syndrome. Invest Ophthalmol Vis Sci 28(3, Suppl):9, 1987.
7. Sternberg P Jr, Han DP, Yeo JH, Barr CC, Lewis H, Williams GA, Mieler WF: Photocoagulation to prevent retinal detachment in acute retinal necrosis. Ophthalmology 94(10, Suppl):70, 1987.
8. Lewis H, Aaberg TM, Abrams GW, Han DP, Williams GA: Current causes of failure following diabetic vitrectomy. Invest Ophthalmol Vis Sci 29(Suppl):220, 1988.
9. Wilkinson WS, Han DP, Rappley MD, Owings CL: Shaken baby syndrome: Relationship between intraocular hemorrhage and neurologic injury. Invest Ophthalmol Vis Sci 29(Suppl):335, 1988.
10. Han DP, Lewis H, Lambrou FH, Mieler WF: Incidence and mechanisms of postvitrectomy glaucoma. Ophthalmology 95(9, Suppl):130, 1988.
11. Han DP, Wilkinson WS: Late ophthalmic manifestations of the shaken baby syndrome. Ophthalmology 95(9, Suppl):180, 1988.
12. Han DP, Abrams GW, Aaberg TM: Surgical excision of the attached posterior hyaloid. Ophthalmology Digest 2:27, 1989.
13. Han DP, Jaffe GJ, Schwartz DM, Lewis H, Abrams GW, Williams GA, Mieler WF, Hartz A, McCarty D: Risk factors for postvitrectomy fibrin formation. Invest Ophthalmol Vis Sci 30(3 Suppl):272, 1989.
14. Mieler WF, Williams DF, Ellis MK, Han DP: Intraocular foreign bodies and endophthalmitis. Invest Ophthalmol Vis Sci 31(4 Suppl):20, 1990.
15. Abrams GW, Murray TG, McKay BS, Han DP: Transcorneal tissue plasminogen activator delivery: A functional in vivo study. Invest Ophthalmol Vis Sci 31(4 Suppl):404, 1990.
16. Murphy ML, Han DP, Mieler WF, Abrams GW: Outpatient fluid-air exchange soon after severe postvitrectomy diabetic vitreous hemorrhage: Results, complications, and long- term follow-up. Invest Ophthalmol Vis Sci 31(4 Suppl):438, 1990.
17. Han DP, Burke JM, McKay BS, Soong HK: Effect of dibutyryl cyclic-3',5'-adenosine monophosphate on actin and vinculin distribution of human and bovine retinal pigment epithelium (RPE) in vitro. Invest Ophthalmol Vis Sci 31(4 Suppl):490, 1990.
18. Hyndiuk R, Murray TG, Palmer M, Boldt HC, Han DP, Mieler WF, Abrams GW: Perfluoro-n-octane: evaluation of anterior segment toxicity associated with intraocular use. Invest Ophthalmol Vis Sci 32(Suppl):880, 1991.
19. Nichols CJ, Boldt HC, Mieler WF, Han DP, Olsen K: Ocular injuries caused by elastic cords. Ophthalmol Digest 4:8, 1991.
20. Wolf MD, Arrindell EL, Han DP: Retinectomies treated by diode laser activated indocyanine green dye-enhanced fibrinogen glue. Invest Ophthalmol Vis Sci 33(Suppl):1316, 1992.
21. Han DP, Murray TG, Boldt HC, Palmer M, Abrams GW, Mieler WF. Perfluoro-n-octane: evaluation of acute anterior segment toxicity with intravitreal use. Invest Ophthalmol Vis Sci 33(Suppl):1313, 1992.
22. Arrindell EL, Wu JC, Wolf MD, Nanda SK, Han DP, Wong EC, Abrams GW, Hyde JS: MRI evaluation of blood-retinal barrier integrity following transconjunctival diode laser photocoagulation and retinal cryotherapy. Invest Ophthalmol Vis Sci 33(Suppl):1125, 1992.
23. Hartz A, Han DP, Wang Q, Murray T, Boldt HC, Arrindell E, Jaffe GJ, Coe E, Mieler WF, Abrams GW, Lewis H, Gottlieb M: The association of postvitrectomy fibrin formation with long-term visual outcome. Invest Ophthalmol Vis Sci 33(Suppl):898, 1992.
24. Piper JG, Han DP, Abrams GW, Mieler WF: Perioperative choroidal hemorrhage at pars plana vitrectomy: a case control study. Ophthalmology 99(Suppl):111-112, 1992.
25. Nanda SK, Han DP. Transconjunctival diode laser retinal photocoagulation through silicone scleral exoplants. Invest Ophthalmol Vis Sci 34(4,Suppl):1212, 1993.
26. Han DP, Ryan EH Jr, Berger AR, Morgan KM, Gupta S, Folk JC, Cantrill HL. Idiopathic central serous chorioretinopathy and choroidal folds. Invest Ophthalmol Vis Sci 34(Suppl):1305, 1993.
27. Rychwalski PJ, Han DP, Mieler WF, Abrams GW. Perfluoro-n-octane and relaxing retinotomies: risks, techniques, and visual outcome. Invest Ophthalmol Vis Sci 34(Suppl):992, 1993.
28. Nash RW, Pulido JS, Mieler WF, Han DP: A prototype semiconductor diode laser coagulator/cutter endoprobe. Invest Ophthalmol Vis Sci 35(4,Suppl):1261, 1994.
29. Simons KB, Han DP, Blair JR, Burke JM: Histopathologic study of autosomal dominant vitreoretinochoroidopathy (ADVIRC) in a 26-year-old woman. Invest Ophthalmol Vis Sci 35(4,Suppl):1958, 1994.
30. Han DP, Pulido JS, Mieler WF: Vitrectomy for diabetic retinopathy and severe peripheral fibrovascular proliferation (PFP). Invest Ophthalmol Vis Sci 35(4,Suppl):1615, 1994.
31. Law SK, Kalenak JW, Connor TB Jr, Mieler WF, Pulido JS, Han DP. Retinal complications following glaucoma tube-shunt surgery. Ophthalmology 102(9A):172, 1995.
32. 32. Han DP, Pulido JS, Mieler WF, Johnson MW. Vitrectomy for proliferative diabetic retinopathy with severe equatorial fibrovascular proliferation. Focus on Diabetic Retinopathy 3(1):16, 1996.
33. Han DP, Wisniewski SR, Kelsey SF, Doft BH, Barza M, Pavan PR, and the Endophthalmitis Vitrectomy Study Group. Comparison of microbiologic yields and complication rates of diagnostic vitreous needle tap and vitreous biopsy in the Endophthalmitis Vitrectomy Study. Invest Ophthalmol Vis Sci 37(3):102, 1996.
34. Law SK, Kalenak JK, Connor TB, Pulido JS, Han DP, Mieler WF. Retinal complications following glaucoma aqueous-shunt surgery. Invest Ophthalmol Vis Sci 37(3):257, 1996.
35. 35 Mieler WF, Chou F, Arrindell EL, Han DP, Pulido JS, Abrams GW. Perfluorocarbon liquids in the management of complicated vitreoretinal conditions. Invest Ophthalmol Vis Sci 37(3):397, 1996
36. Chou F, Mieler WF, Han DP, Pulido JS. Results of surgery for giant retinal tears pre- and post- perfluorocarbon liquids. Invest Ophthalmol Vis Sci 37(3):397, 1996
37. Tang WM, Pulido JS, Han DP, Mieler WF. HLA-DR2+ intermediate uveitis. Invest Ophthalmol Vis Sci 37(3):1038, 1996
38. Postel EA, Heier J, Pulido JS, Waterhouse W, Han DP, Mieler WF. Long-term follow- up of iatrogenic phototoxicity. Invest Ophthalmol Vis Sci 37(3):1150, 1996
39. Law SK, Kalenak JW, Trible JR, Connor TB, Pulido JS, Han DP, Mieler WF. Retinal complications following Ahmed Valve Implantation. Ophthalmology 103(9A):147, 1996.
40. Cohen SM, Han DP, Johnson MW, Gass JD. Foveal retinoschisis in females. Ophthalmology 103(9A):185, 1996.
41. Wirostko WJ, Han DP, Mieler WF, Pulido JS, Connor TB, Kuhn E. Suprachoroidal hemorrhage: outcome of surgical management according to hemorrhage severity. Invest Ophthalmol Vis Sci 38(4):S670, 1997.
42. Banker AS, Freeman WR, Azen SP, the Vitrectomy for Macular Hole Study Group. A multicentered clinical trial of serum as adjuvant therapy for surgical treatment of macular holes. Invest Ophthalmol Vis Sci 38(4):S736, 1997.
43. Tang W, Han DP. Surgical manipulation of the retinal vasculature. Invest Ophthalmol Vis Sci 38(4):S752, 1997.
44. Han DP, Mohsin N, Guse CE, Hartz AJ, Tarkanian C, Wolf MD, Sramek SJ, Mieler WF, Pulido JS, Connor TB. Comparison of pneumatic retinopexy versus scleral buckling in the management of primary rhegmatogenous retinal detachment. Invest Ophthalmol Vis Sci 38(4):S483, 1997.
45. Law SK, Kalenak JW, Trible JR, Connor TB, Pulido JS, Han DP, Mieler WF. Postoperative hypotony and retinal complications following Ahmed glaucoma valve implantation. Invest Ophthalmol Vis Sci 38(4):S12, 1997.
46. Chandry NA, Alfaro VA, Gonzales G, Chen HH, Han DP, Mieler WF, Liggett PE. Preoperative use of tissue plasminogen activator (tPA) for surgical removal of submacular hemorrhage. Invest Ophthalmol Vis Sci 38(4):S657, 1997.
47. Mittra RA, Connor TB, Han DP, Mieler WF, Pulido JS. Management of dislocated posterior chamber lenses using pars plana vitrectomy combined with insertion of an anterior chamber lens. Invest Ophthalmol Vis Sci 38(4): S667, 1997.
48. McCabe CM, Mieler WF, Han DP, Pulido JS, Connor TB. Retinal detachment following macular hole surgery. Invest Ophthalmol Vis Sci 38(4):S737, 1997.
49. Han DP, Simons KB, Tarkanian CN, Moretti ST. Endophthalmitis from mycobacterium bovis-bacille Calmette-Guerin after intravesicular BCG injections for bladder carcinoma. Ophthalmology (American Academy of Ophthalmology Meeting Supplement to Ophthalmology, November 1998.)
50. Mittra RA, Pollack JS, Dev S, Han DP, Mieler WF, Connor TB, Pulido JS. The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade. Invest Ophthalmol Vis Sci 39(4):S376, 1998.
51. Dev S, Pulido JS, Tessler HH, Mittra RA, Han DP, Connor TB, Mieler WF. Progression of diabetic retinopathy after endophthalmitis. Invest Ophthalmol Vis Sci 39(4):S674, 1998.
52. Han DP, Simons KB, Tarkanian CN, Moretti ST. Endophthalmitis from mycobacterium bovis-bacille Calmette-Guerin after intravesicular BCG injections for bladder carcinoma. Invest Ophthalmol Vis Sci 40 (4):S116, 1999.
53. Levin DS, Dev S, Wirostko WJ, Han DP, Mieler WF, Connor TB. Posterior subtenon corticosteroid injections in patients with a history of corticosteroid-induced IOP elevation. Invest Ophthalmol Vis Sci 40 (4):S384, 1999.
54. Sramek SJ, Han DP, Kim JE. Limited retinal translocation in age-related macular degeneration. Invest Ophthalmol Vis Sci 41:S182, 2000.
55. Levin DS, Wirostko WJ, Borrillo JL, Perkins SL, Phillips JR, Han DP, Koenig SB, Kim JE. Vitreoretinal B-scan echographic findings of eyes with infectious keratitis. Invest Ophthalmol Vis Sci 41:S353, 2000.
56. Perkins SL, Kim JE, Wirostko WJ, Han DP, Connor TB. Clinical characteristics of central serous retinopathy in women. Invest Ophthalmol Vis Sci 41:S358, 2000.
57. Young JE, Kurz D, Bao Y, Newman S, Conway BP, Han DP, Gonzales-Fernandez F, Khani SC. 11-cis retinol dehydrogenase (RDH5) gene mutations in fundus albipunctatus patients. Invest Ophthalmol Vis Sci 41:S615, 2000.
58. Carnahan MC, Wirostko WJ, Perkins SL, Han DP, Kim JE, Connor TB. Safety of cataract extraction following central retinal vein occlusion. . Invest Ophthalmol Vis Sci 41:S645, 2000.
59. Hong PH, Han DP, Burke JM, Wirostko WJ. Vitrectomy for large vitreous opacity in retinitis pigmentosa: an ultrastructural evaluation. . Invest Ophthalmol Vis Sci 41:S882, 2000.
60. Carnahan MC, Wirostko WJ, Perkins SL, Kim JE, Connor TB, Han DP. The vitreoretinal use of perfluorocarbon liquid in the pediatric population. Invest Ophthalmol Vis Sci 40 (4):S430, 2001.
61. Saadati HG, Han DP, Farzad S, Perkins SL. Clinical disappearance and reappearanceof optic nerve coloboma with transient serous macular detachment and macular schisis. Invest Ophthalmol Vis Sci 42 (4):S432, 2001.
62. Kim JE, Perkins SL, Connor TB, Wirostko, WJ, Han DP. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization. Invest Ophthalmol Vis Sci 40 (4):S443, 2001.
63. Shah KB, Kim JE, Connor TB, Wirostko WJ, Han DP. Transpupillary thermotherapy plus indocyanine green dye enhancement for the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci, Program summary abstract #1819, May 4-9, 2003.
64. Ryan EH, Han DP. Diabetic macular edema due to glitazone use: a new finding. Ophthalmology/AAO abstract supplement. October 2003.
65. Lemley CA, Han DP. 12 Years experience with pediatric pars plana vitrectomy using morphometric data to plan sclerotomy site location. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, April 30-May 4, 2006.
66. Covert DJ, Wirostko WJ, Han DP, Lindgren KE, Hammersley JA, Connor TB, Jr., Kim JE. Risk factors for scleral buckle removal: a matched, case-control study. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, April 17-May 1, 2008.
67. Hammersley J, Covert DJ, Han DP, Wirostko WJ, Lindgren KE, Connor TB, Kim JE. Outcomes and complications of scleral buckle removal. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 3-7, 2009.
68. Schell JC, Stepien KE, Han DP, Carroll J, Rha J. Spectral-domain OCT may be able to detect Plaquenil toxicity before symptomatic vision loss occurs. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 3-7, 2009.
69. Wee R, Han DP, Shah GK. Visual and anatomical outcomes following vitrectomy for secondary epiretinal membranes following therapy for wet age-related macular degeneration. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 3-7, 2009.
70. Covert DJ, Han DP, Ruttum MS. Pars plicata lensectomy and vitrectomy for congenital cataracts. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 3-7, 2009.
71. Henry CR, Covert DJ, Han DP, Sanchez CR, Bhatia SK. Risk factors for rhegmatogenous retinal detachment following pars plana vitrectomy for epiretinal membrane and macular hole. Annual Meeting of the Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, May 2-6, 2010.

© 2026 Clinical & Translational Science Institute
Medical College of Wisconsin
8701 Watertown Plank Road
Milwaukee, WI 53223

Publication and ontology data from NCBI | Disclaimer and Copyright

This site is a collaborative effort of the Medical College of Wisconsin and the Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number 2UL1TR001436) at the National Institutes of Health (NIH).

Faculty Collaboration Database

Profiles for MCW, MU, MSOE, UWM, BCW, CW, Froedtert, and VA Faculty